SCHEMBL3132792

SCHEMBL3132792

CC(C)(C)OC(=O)c1cccc(N(Cc2cnccn2)c2ccc(OC(F)F)c(OC(F)F)c2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.35
SLC7A5 Q01650 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PDE4D Q08499 5/20 0.33
PDE4B Q07343 4/20 0.33
PDE4A P27815 3/20 0.33
PDE4C Q08493 3/20 0.33
MEN1 O00255 1/20 0.33
TSHR P16473 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
KDM4E B2RXH2 1/20 0.33
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33
FGFR4 P22455 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3215279 0.97 RXRA (0.35) KMT2AMAPTPOLBLMNAGAA
SCHEMBL3131342 0.92 HDAC6 (0.37) KMT2AMAPTPOLBLMNAGAA
SCHEMBL3129536 0.91 PDE4D (0.46) PDE4DPDE4BPDE4APDE4C
SCHEMBL3129505 0.89 RXRA (0.38) KMT2AMAPTPOLBLMNAGAA
SCHEMBL3193436 0.88 SYK (0.37) KMT2APOLBLMNAGAARAB9A
SCHEMBL3200145 0.88 SYK (0.37) KMT2AGAARAB9APDE4DPDE4B
SCHEMBL3132484 0.87 PDE4D (0.39) KMT2AMAPTPOLBLMNAGAA
SCHEMBL4189294 0.87 LMNA (0.37) KMT2AMAPTPOLBLMNASLC7A5
SCHEMBL4197448 0.87 HCRTR1 (0.37) SLC7A5TDP1PDE4DPDE4B
SCHEMBL3215299 0.87 HDAC6 (0.37) KMT2AMAPTLMNAGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed
WO-2010003084-A2 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B KMT2A 1324/4885MAPT 4197/4885POLB 1798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.